Page last updated: 2024-10-30

losartan and Besnier-Boeck Disease

losartan has been researched along with Besnier-Boeck Disease in 2 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
" This case report presents the successful treatment of severe heart failure with prednisone, glycosides and an angiotensin-1 receptor antagonist."3.70[Heart failure as a cardiac symptom of sarcoidosis. Successful treatment of heart failure with steroids, digitalis and an angiotensin-1-receptor antagonist in sarcoidosis]. ( Erbel, R; Kuntz, S; Oldenburg, O; Philipp, T; Sack, S; Schäfers, RF; Weber, F, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamorro-Pareja, N1
Marin-Acevedo, JA1
Chirilă, RM1
Oldenburg, O1
Schäfers, RF1
Kuntz, S1
Sack, S1
Erbel, R1
Philipp, T1
Weber, F1

Reviews

1 review available for losartan and Besnier-Boeck Disease

ArticleYear
Cardiac sarcoidosis: Case presentation and Review of the literature.
    Romanian journal of internal medicine = Revue roumaine de medecine interne, 2019, Mar-01, Volume: 57, Issue:1

    Topics: Cardiomyopathies; Cardiovascular Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressiv

2019

Other Studies

1 other study available for losartan and Besnier-Boeck Disease

ArticleYear
[Heart failure as a cardiac symptom of sarcoidosis. Successful treatment of heart failure with steroids, digitalis and an angiotensin-1-receptor antagonist in sarcoidosis].
    Medizinische Klinik (Munich, Germany : 1983), 2000, Mar-15, Volume: 95, Issue:3

    Topics: Adult; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Cardiomyopathies; Digitoxin; Drug Therapy,

2000